These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20013808)

  • 1. Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line.
    Dos Santos C; Karaky R; Renoir D; Hamma-Kourbali Y; Albanese P; Gobbo E; Griscelli F; Opolon P; Dalle S; Perricaudet M; Courty J; Delbé J
    Int J Cancer; 2010 Sep; 127(5):1038-51. PubMed ID: 20013808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HARPΔ111-136 enhances radiation-induced apoptosis of U87MG glioblastoma by induction of the proapoptotic protein CHOP.
    Karaky R; Gobbo E; Opolon P; Delbé J; Courty J; Griscelli F; Perricaudet M; Martel-Renoir D
    Int J Oncol; 2011 Jan; 38(1):179-88. PubMed ID: 21109939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.
    Zhu Y; Zhao K; Prinz A; Keyvani K; Lambertz N; Kreitschmann-Andermahr I; Lei T; Sure U
    Neuro Oncol; 2016 Apr; 18(4):538-48. PubMed ID: 26254477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma.
    González-Gómez P; Crecente-Campo J; Zahonero C; de la Fuente M; Hernández-Laín A; Mira H; Sánchez-Gómez P; Garcia-Fuentes M
    Oncotarget; 2015 May; 6(13):10950-63. PubMed ID: 25860932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
    Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
    Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
    Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
    Grzelinski M; Bader N; Czubayko F; Aigner A
    Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthetic peptide P111-136 derived from the C-terminal domain of heparin affin regulatory peptide inhibits tumour growth of prostate cancer PC-3 cells.
    Hamma-Kourbali Y; Bermek O; Bernard-Pierrot I; Karaky R; Martel-Renoir D; Frechault S; Courty J; Delbé J
    BMC Cancer; 2011 May; 11():212. PubMed ID: 21624116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironment involved in FPR1 expression by human glioblastomas.
    Boer JC; van Marion DM; Joseph JV; Kliphuis NM; Timmer-Bosscha H; van Strijp JA; de Vries EG; den Dunnen WF; Kruyt FA; Walenkamp AM
    J Neurooncol; 2015 May; 123(1):53-63. PubMed ID: 25894595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
    Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
    Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
    Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
    Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
    Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
    BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of cysteine cathepsins and cystatins in human gliomas.
    Gole B; Huszthy PC; Popović M; Jeruc J; Ardebili YS; Bjerkvig R; Lah TT
    Int J Cancer; 2012 Oct; 131(8):1779-89. PubMed ID: 22287159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCoR controls glioblastoma tumor cell characteristics.
    Heldring N; Nyman U; Lönnerberg P; Onnestam S; Herland A; Holmberg J; Hermanson O
    Neuro Oncol; 2014 Jan; 16(2):241-9. PubMed ID: 24335696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo.
    Denicolaï E; Baeza-Kallee N; Tchoghandjian A; Carré M; Colin C; Jiglaire CJ; Mercurio S; Beclin C; Figarella-Branger D
    Oncotarget; 2014 Nov; 5(21):10934-48. PubMed ID: 25400117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Let-7 microRNA inhibits the proliferation of human glioblastoma cells.
    Lee ST; Chu K; Oh HJ; Im WS; Lim JY; Kim SK; Park CK; Jung KH; Lee SK; Kim M; Roh JK
    J Neurooncol; 2011 Mar; 102(1):19-24. PubMed ID: 20607356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.
    Uchinokura S; Miyata S; Fukushima T; Itoh H; Nakano S; Wakisaka S; Kataoka H
    Int J Cancer; 2006 Feb; 118(3):583-92. PubMed ID: 16106403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
    Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
    Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1.
    Lee JS; Xiao J; Patel P; Schade J; Wang J; Deneen B; Erdreich-Epstein A; Song HR
    Neuro Oncol; 2014 Jan; 16(2):191-203. PubMed ID: 24305710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.